AzTrials
AzTrials

Bowel PerforatedDANAKIRNCT05442164

Effect of Implementation of the Danish Emergency Surgery (DANAKIR) Support Network on Post-discharge Outcomes After Major Emergency Abdominal Surgery

An observational study of Bowel Perforated and Bowel Obstruction, run by Herlev Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Effect of implementation of the Danish Emergency Surgery (DANAKIR) support Network on post-discharge outcomes after major emergency abdominal surgery: a prospective before and-after study Background Major emergency abdominal surgery is performed in more than 5000 patients yearly in Denmark. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Bowel Perforated, Bowel Obstruction
What is being tested?
DANAKIR support network
How many people
400 participants
Where
No sites listed yet
Study dates
1 Sep 2022to 31 Aug 2023
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients at the department of Surgery, Herlev Hospital. A large University Hospital in the Capital Region of Denmark

Who may be able to join

  • Emergency open, laparoscopic or laparoscopically assisted procedures involving: stomach, small bowel, large bowel, or rectum for conditions such as perforation, ischemia, abdominal abscess, bleeding, haematoma, or obstruction
  • Bowel resection due to incarcerated incisional, umbilical, inguinal, and femoral hernias (but not hernia repair without bowel resection/repair)
  • Laparoscopic/open adhesiolysis
  • Fascial dehiscence
  • Emergency surgery after elective surgery if criteria above is met

Who cannot join

  • Elective procedures
  • Appendectomy +/- drainage of localized abscess
  • Cholecystectomy +/- drainage of localized abscess
  • Emergency hernia repair without bowel resection
  • Large-bowel endoscopic stent procedures
  • Superficial wound dehiscence above the fascia
  • Ruptured ectopic pregnancy or pelvic abscess due to inflammatory disease

Trial locations and contacts

No sites are listed yet.

Dunja K Gellert-Kristensen, MD, PhD contact

28776364

dunja.kokotovic.gellert-kristensen@regionh.dk

About this study

Official title: Effect of Implementation of the Danish Emergency Surgery (DANAKIR) Support Network on Post-discharge Outcomes After Major Emergency Abdominal Surgery: a Prospective Before And-after Study

Effect of implementation of the Danish Emergency Surgery (DANAKIR) support Network on post-discharge outcomes after major emergency abdominal surgery: a prospective before and-after study

Background Major emergency abdominal surgery is performed in more than 5000 patients yearly in Denmark. In general, little is known about the period after the discharge of these patients besides that chronic pain, physical dysfunction, and quality of life are severely affected in up to 50% of patients at long-term follow-up. A recent study investigating unplanned readmission after major emergency abdominal surgery found that up to 50% undergo unplanned readmission within the first 180 days after discharge.

Read more

Purpose The purpose of this study is to evaluate the effects of inviting patients undergoing major emergency surgery and their relatives to join a support network after discharge (the DANAKIR network).

Methods This study is designed as a before- and after study. Prior to establishing the DANAKIR (Danish Emergency Surgery Network) support network, the investigators will consecutively during a one year inclusion period prospectively include all patients undergoing emergency abdominal surgery with a midline laparotomy. The inclusion period starts 1st August 2021.

The investigators will register the following in the pre-implementation phase:

  • Postoperative day (POD) 30: Quality of life (EQ-5D-5L) (by telephone)
  • POD90: Quality of life (EQ-5D-5L) (by telephone), readmissions (by hospital file)
  • POD 180: Quality of life (EQ-5D-5L) (by telephone), readmissions (by hospital file)
  • Number of days at home with 90 days (by hospital file)
  • Number of participants with at least one readmission (by hospital file) Hereafter the investigators will establish the DANAKIR support network. The investigators plan for a six-month inclusion period with DANAKIR starting 1th of September 2022

Intervention

The DANAKIR intervention will consist of:

  • Structured written discharge information for the participanats and relatives about expectations and precautions
  • Invitation to the DANAKIR monthly information meeting All patients undergoing emergency abdominal surgery and members of their family are invited to participate in at least one DANAKIR meeting. Patients and their relatives can participate in as many meetings as they wish; however, we encourage all patients to participate at least once.

DANAKIR meetings The monthly meetings are a core component of the support network. One time each month, a meeting will be held at Herlev Hospital with the participation of an emergency surgeon, an emergency surgery dedicated nurse, a dietician, and a physiotherapist. Furthermore, there will be research personnel present. Each professional (surgeon, nurse, dietician, physiotherapist) will host an informative 15 minute session regarding the postoperative course after major emergency surgery. Following the presentations time for questions in plenum and private with the different experts will be held. Furthermore, there will be an opportunity for networking at the DANAKIR meeting. Each meeting is planned to last 2 hours. At the end of each meeting the patients will be asked to evaluate the meeting and content.

Outcome measures The primary outcome of this study is the number of days at home within 90 days of surgery. The secondary outcomes are quality of life at 30 days, 90 days, and 180 days after surgery and the number of patients with at least one emergency readmission 90 days and 180 days from surgery.

Trial size The investigators expect to include 200 patients in the before group and 200 patients in the after group.

Perspectives The DANAKIR support network examines if a structure with physical network meetings is effective in regard to quality of life and preventing readmissions after major emergency surgery. The investigators hypothesize that the days at home will increase within 90 days from surgery and that quality of life will increase for both participants and their relatives by implementing a simple and obvious solution. If the DANAKIR network proves efficient it is an easily implemented solution to increase quality of life and days at home after major emergency surgery.

Being tested
DANAKIR support network
Medical subject headings
Intestinal Perforation, Intestinal Obstruction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DANAKIR support networkBehavioural

    The DANAKIR intervention will consist of:

    • Structured written discharge information
    • Invitation to the DANAKIR monthly information meeting DANAKIR meetings The monthly meetings are a core component of the support network. One time each month, a meeting will be held at Herlev Hospital with the participation of an emergency surgeon, an emergency surgery dedicated nurse, a dietician, and a physiotherapist. Each professional (surgeon, nurse, dietician, physiotherapist) will host an informative 15 minute session regarding the postoperative course after major emergency surgery. Following the presentations time for questions in plenum and private with the different experts will be held. Furthermore, there will be an opportunity for networking at the DANAKIR meeting. Each meeting is planned to last 2 hours. At the end of each meeting the patients will be asked to evaluate the meeting and content.
Study groups in NCT05442164
Study groupRoleWhat they receive
Before-groupPatients undergoing major emergency surgery before a supportive network is established
After-groupPatients undergoing major emergency surgery after a supportive network is established
Receives: Behavioral: DANAKIR support network

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Days at home within 90 days

    Number of days at home within 90 days of surgery

    Measured: 90 day

Secondary outcomes (2)
  1. Quality of life

    EQ-5D-5L

    Measured: Day 30, day 90, day 180

  2. Readmission

    number of patients with at least one emergency readmission

    Measured: Day 90 and day 180

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2022
  2. Study start1 Sep 2022 (estimated)
  3. Primary completion28 Feb 2023 (estimated)
  4. Study completion31 Aug 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
400 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT05442164
Sponsor's protocol ID
DANAKIR
Acronym
DANAKIR
Status last verified
Jul 2022
First submitted
28 Jun 2022
Last updated
7 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bowel Perforated and Bowel Obstruction, run by Herlev Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dunja K Gellert-Kristensen, MD, PhD (28776364, dunja.kokotovic.gellert-kristensen@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Days at home within 90 days (time frame: 90 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in